Presentation is loading. Please wait.

Presentation is loading. Please wait.

Incontinence and Erectile Dysfunction

Similar presentations


Presentation on theme: "Incontinence and Erectile Dysfunction"— Presentation transcript:

1 Incontinence and Erectile Dysfunction
Male Incontinence Female Incontinence Male Erectile Dysfunction What the urologist can do for your patient

2 Male Incontinence There are essentially 4 types of Incontinence
Overflow Urge Neurogenic Stress

3 Overflow Incontinence
Bladder overfilling and subsequent leakage- Dx by residual urine Treatment Catheterization intermittent or continuous Eliminate drugs that cause poor bladder contraction : anticholinergics Interstim therapy

4 Overflow Incontinence
BPH is the most common cause Treatment Alpha blockers: Flomax, Uroxatral, Rapaflo,Cardura and Hytrin TUR Prostate Green Light Laser Prostatectomy Microwave thermotherapy

5 BPH treatment TUR Prostate is has been a gold standard for years
Complications: Bleeding and Blood loss Fluid absorption during the procedure Rare incontinence

6 Green Light laser Prostatectomy
Becoming the new standard Becoming more common that TURP The operation is the removal of the same tissue (Prostate Adenoma) by vaporization rather than cutting it out. Almost no bleeding No fluid absorption Can be done with sedation (even in office)

7 Green Light laser Prostatectomy
Advantages of office procedure Less stressful for patient Less cost for the patient and the health care system

8

9

10 Microwave Thermotherapy
A catheter is placed in the urethra and microwave heat is applied to the prostate Results: Minimally invasive office procedure for poor surgical risk patients Other patients may request it

11 Urgency Incontinence Inability to control an unstable bladder contraction Etiology: MS, CVA, and idiopathic, BPH Diagnosis: Urodynamic studies Treatment: If secondary to obstruction e.g. BPH, treat BPH first

12 Urgency Incontinence Anticholinergic medications: Detrol, Enablex, Vesicare, Sanctura, Oxybutinin, Oxytrol patch, Gelnique Botox injection Behavioral Therapy Interstim therapy Percutaneous Tibial Nerve Stimulation

13 Botox injection I have been doing this for 4 years Office procedure
Units ( 10 units per CC) of Botox A injected submucosally in the bladder 90 % patients respond; usual response is within 8 days and lasts 6month to two years Complication: retention

14 Interstim Therapy Neuromodulation of S3 or S4 nerve root
Why it works is unknown 50 % response rate Staged procedure: Place electrode and stimulate as outpatient; if successful implant batter stimulator and attach electrode

15 Interstim Therapy Single Stage procedure in OR Two Stage Procedure

16 PTNS Weekly tibial nerve stimulation
Office procedure that lasts one hour Needs 12 treatments Lasts 12 months 50 % improvement in nocturia, incontinence, episodes, and OAB score

17 PTNS

18 Neurogenic Incontinence
Spinal cord injury Retention Spastic Bladder

19 Neurogenic Bladder Etiology is spinal cord lesion and trauma most common Most patients will have spinal shock and be in retention and best handled by intermittent catheterization Follow up Urodynamic studies

20 Retention Usually motor neuron lesion and will require intermittent catheterization for life Can construct a continent suprapubic stoma (appendix) if urethral catheterization not acceptable or possible Occasionally due to spastic sphincter and treatment of choice is Botox injection of the external sphincter

21 Spastic Bladder Usually secondary to Upper spinal cord lesion
Treatment with imipramine, anticholinergic and alpha blocker together If no results, then Botox If no results then diversion or bladder augmentation and IC

22 Stress incontinence Etiology is usually surgery and usually radical prostatectomy for cancer This is manifest with urinary leakage with cough or abdominal straining Treatment: Advance Sling or AMS 800 urinary sphincter

23 Advance Sling Used when there only stress incontinence and there is mobility of the urethra Outpatient procedure Success of 90% Risk of early retention

24 Mechanism of Action for AdVance Sling
Image: Peter Rehder

25 AdVance Transobterator Male Sling
Introduced to the market in 2007

26 AMS 800 Urinary Sphincter Can be used for stress in all circumstances
Usually used for stress incontinence when there is no urethral mobility Used for total incontinence Success rate 95% Risk: infection; retention and erosion

27 AMS Sphincter

28 AMS Sphincter Artificial Sphincter-over 65,000 procedures
The Gold Standard for treatment of moderate to severe incontinence Minimally invasive Outpatient procedure 92% of patients would have the AMS 800 placed again 96% of patients would recommend it to a friend 33 years on the market

29 Female Incontinence Overflow Urgency Neurogenic Stress

30 Female Overflow Incontinence
Diabetic neuropathy Lumbar Disc disease Herpes Simple or Zoster Post-op especially gyn surgery Anticholinergic agents Rare urethral or bladder cancer

31 Overflow Incontinence RX
Intermittent Catheterization Interstim therapy Alpha blockade

32 Urgency Incontinence Overactive Bladder R/O <Multiple sclerosis CVA
Interstitial cystitis Acute urgency: cystitis, lower stone

33 Rx urge incontinence Anticholinergics Botox Interstim PTNS
Behavior therapy

34 Neurogenic incontinence
Convert to a hypotonic bladder Botox Augmentation Anticholinergics Then start intermittent catheterization

35 Female Stress Incontinence
Inability to control leakage with Cough Strain Sneeze Valsalva

36 Female Stress Incontinence
This is an anatomic problem which is corrected anatomically Type 2 Hypermobile urethra Type 3 rigid urethra

37 RX of Type 2 and Type 3 Slings Transobturator Retropubic

38 Slings for Stress Incontinence
Considered minimally invasive surgery First developed in mid 1990’s A sling or hammock shape material is placed below the urethra Incisions are very small Long term data shows success of over 80%* * Long-Term Results of the Tension-Free Vaginal Tape (TVT) Procedure for Surgical Treatment of Female Stress Urinary Incontinence, Nilsson et. al, International Urology Journal, 2001.

39 Stress Incontinence Solutions
Sling or Hammock Incisions are very small Procedure pain is minimal* Recovery time is less than half the time of Burch procedure* Patient usually goes home the same day Products like SPARC™, TVT™, or Monarc™ Subfascial Hammock Will play animation here * Burch Colposuspension and Tension-Free Vaginal Tape in the Management of Stress Urinary Incontinence in Women, Liapis et. al, European Urology, 2002,

40 Urethral Implant Collagen Macroplastique Durasphere

41                                                                                                                                                                                   Product Photo Library Contigen® Implant Syringe Open Bladder Neck Transurethral Technique Step 1 Transurethral Technique Step 2 Periurethral Technique Step 1 Periurethral Technique Step 2 Periurethral Technique Tip 1 Periurethral Technique Tip 2 Periurethral Technique Tip 3                                                                                                                   Pass the needle through the cystoscope sheath Place the needle into the side of the urethra beneath the mucosa proximal to the external sphincter (i.e., towards the bladder neck) No injection should take place either in the external sphincter or around the bulbous urethra                                

42 Erectile Dysfunction Inability to obtain or maintain an erection satisfying for intercourse

43 Physical Causes of ED • Diabetes • Heart disease
• Surgery (Prostate, Bladder, Colon, Rectal) • Medications • Spinal injury • Hormone imbalance

44 Available treatments PDE- Inhibitors
Prostaglandin and papavarine injection Testosterone for hypogonadism Vacuum Pump Penile Implants

45 Oral Therapies: Work only in response to sexual stimulation
Must take Viagra and Levitra at least ½ hour before anticipated sexual activity. They remains effective for up to 4 hours after are they taken Cialis can last as long as 36 hours

46 Vacuum Erection Device:
Externally applied device mechanically effects penile blood engorgement Cylinder/pump placed over penis creates closed chamber; pump creates vacuum, drawing blood into corpora cavernosa Constrictive elastic ring then placed at base of penis to restrict flow of suctioned blood VED: Basic Principles VEDs are a useful noninvasive treatment for ED. They involve a cylindrical device that is placed over the penis. Many types of VEDs are now available, and it is recommended that only those available by prescription should be used.1,2 A VED, which mechanically creates penile blood engorgement, consists of a vacuum chamber or cylinder, a pump to produce negative pressure, and constriction rings.3 VEDs can be used to treat organic or psychogenic ED. Current reviews report successful results in men with a variety of organic etiologies, including spinal cord injuries, postprostatectomy, diabetes, and arterial insufficiency.3 After the penis and constriction rings are coated with water-soluble lubricant and the rings are loaded onto the cylinder base, the cylinder is placed over the penis with the base held firmly against the pubis to maintain a seal. The pump is then activated to slowly create negative pressure, or a vacuum, inside the cylinder, which draws blood into the corpora cavernosa, producing an erection.1,3 Once the penis is engorged, the constriction band is pulled from the cylinder onto the base of the penis. The negative pressure is released through a valve, and the cylinder is removed. It takes an average of 2 to 2½ minutes to create an erection through this procedure, according to recent reviews.3 The erectile state produced by VEDs differs from a normal erection: penile skin temperature is lower, the veins of the penis appear distended, and penile circumference is increased. In addition, the penis may pivot at the base, requiring the patient to stabilize the penis during intercourse.1 Montague DK, et al, for the AUA Guidelines Panel on Erectile Dysfunction. J Urol. 1996;156: Donatucci CF. In: Mulcahy JJ, ed. Male Sexual Function. Totowa, NJ: Humana Press Inc; 2001: Levine LA, Dimitriou RJ. Urol Clin North Am. 2001;28: Levine LA, Dimitriou RJ. Urol Clin North Am. 2001;28: Montague DK, et al, for the AUA Clinical Guidelines Panel on Erectile Dysfunction. J Urol. 1996;156:

47 Transurethral Medication: MUSE

48 Transurethral Medication: MUSE

49 Injection Therapy Diabetic needle and syringe
Drug dosage - 1 cc or less 5-15 minute response time 30 minute to 2 hour duration Possible side effects Pain on administration Prolonged erections Scarring

50 Penile Injection Therapy:
Smooth muscle – relaxing medication injected directly into the penis

51 Penile Implants vs. Other Treatment Options
Overall Patient Satisfaction with ED Treatments1 0% 20% 40% 60% 80% 100% Penile Implant Oral Medication Injection 93% 51% 40% Percentage Satisfied 1 Rajpurkar A, Dhabuwala CB. Comparison of satisfaction rates and erectile function in patients treated with sildenafil, intracavernous prostaglandin E1 and penile implant surgery for erectile dysfunction in urology practice. J Urol Jul 2003 v.170(1)p

52 Penile Implants Ideal for men who have tried other
treatments without success • On the market for over 30 years • 25,000 penile implants per year • High patient and partner satisfaction

53 Three – Piece Inflatable Penile Implant
Acts and feels more like a natural erection Expands the girth of the penis More firm and full than other implants Feels softer and more flaccid when deflated

54 How does it work? Fluid flows from the small reservoir in the abdomen into the cylinders of the penis when the pump is squeezed until there is a firm erection. Once the erection is not needed you squeeze the pump which allows the fluid to return to the reservoir.

55 Implants are Highly Recommended
100% 95% 90% 85% 80% 92% would recommend to others3 90% partners would recommend to other couples4 Levine LA, Estrada CR, Morgentaler A. Mechanical reliability and safety of, and patient satisfaction with the Ambicor inflatable penile prosthesis; results of a 2 center study. J Urol Sep; 166 (3) :932-7

56 Q & A


Download ppt "Incontinence and Erectile Dysfunction"

Similar presentations


Ads by Google